Talis Biomedical Corp Annual Net Cash Provided by (Used in) Investing Activities in USD from 2020 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Talis Biomedical Corp quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2020 to 2023.
- Talis Biomedical Corp Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $30K.
- Talis Biomedical Corp annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$486K, a 69.9% increase from 2022.
- Talis Biomedical Corp annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$1.62M, a 43.7% increase from 2021.
- Talis Biomedical Corp annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$2.87M, a 65.1% increase from 2020.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)